Giovannetti E - Search Results

1

HGF/MET pathway aberrations as diagnostic, prognostic, and predictive biomarkers in human cancers.

Moosavi F, Giovannetti E, Saso L, Firuzi O. Moosavi F, et al. Among authors: giovannetti e. Crit Rev Clin Lab Sci. 2019 Dec;56(8):533-566. doi: 10.1080/10408363.2019.1653821. Epub 2019 Sep 12. Crit Rev Clin Lab Sci. 2019. PMID: 31512514 Review.

2

Enhancement of the antiproliferative activity of gemcitabine by modulation of c-Met pathway in pancreatic cancer.

Avan A, Quint K, Nicolini F, Funel N, Frampton AE, Maftouh M, Pelliccioni S, Schuurhuis GJ, Peters GJ, Giovannetti E. Avan A, et al. Among authors: giovannetti e. Curr Pharm Des. 2013;19(5):940-50. Curr Pharm Des. 2013. PMID: 22973962

3

Molecular mechanisms underlying the role of microRNAs in resistance to epidermal growth factor receptor-targeted agents and novel therapeutic strategies for treatment of non-small-cell lung cancer.

Maftouh M, Avan A, Galvani E, Peters GJ, Giovannetti E. Maftouh M, et al. Among authors: giovannetti e. Crit Rev Oncog. 2013;18(4):317-26. doi: 10.1615/critrevoncog.2013007191. Crit Rev Oncog. 2013. PMID: 23614618 Review.

4

MET as a potential target for the treatment of upper gastrointestinal cancers: characterization of novel c-Met inhibitors from bench to bedside.

Avan A, Maftouh M, Funel N, Ghayour-Mobarhan M, Boggi U, Peters GJ, Giovannetti E. Avan A, et al. Among authors: giovannetti e. Curr Med Chem. 2014;21(8):975-89. doi: 10.2174/09298673113209990231. Curr Med Chem. 2014. PMID: 23992325 Review.

5

Circulating microRNAs as diagnostic biomarkers for pancreatic cancer.

Le Large TY, Meijer LL, Prado MM, Kazemier G, Frampton AE, Giovannetti E. Le Large TY, et al. Among authors: giovannetti e. Expert Rev Mol Diagn. 2015;15(12):1525-9. doi: 10.1586/14737159.2015.1112273. Epub 2015 Nov 15. Expert Rev Mol Diagn. 2015. PMID: 26567751

6

cMET Exon 14 Skipping: From the Structure to the Clinic.

Van Der Steen N, Giovannetti E, Pauwels P, Peters GJ, Hong DS, Cappuzzo F, Hirsch FR, Rolfo C. Van Der Steen N, et al. Among authors: giovannetti e. J Thorac Oncol. 2016 Sep;11(9):1423-32. doi: 10.1016/j.jtho.2016.05.005. Epub 2016 May 17. J Thorac Oncol. 2016. PMID: 27223456 Free article. Review.

7

Never let it go: Stopping key mechanisms underlying metastasis to fight pancreatic cancer.

Giovannetti E, van der Borden CL, Frampton AE, Ali A, Firuzi O, Peters GJ. Giovannetti E, et al. Semin Cancer Biol. 2017 Jun;44:43-59. doi: 10.1016/j.semcancer.2017.04.006. Epub 2017 Apr 22. Semin Cancer Biol. 2017. PMID: 28438662 Free article. Review.

8

Double Trouble: A Case Series on Concomitant Genetic Aberrations in NSCLC.

Van Der Steen N, Mentens Y, Ramael M, Leon LG, Germonpré P, Ferri J, Gandara DR, Giovannetti E, Peters GJ, Pauwels P, Rolfo C. Van Der Steen N, et al. Among authors: giovannetti e. Clin Lung Cancer. 2018 Jan;19(1):35-41. doi: 10.1016/j.cllc.2017.06.010. Epub 2017 Jul 6. Clin Lung Cancer. 2018. PMID: 28757336 Review.

9

Noncoding Rnas Emerging as Novel Biomarkers in Pancreatic Cancer.

Garajová I, Balsano R, Tommasi C, Giovannetti E. Garajová I, et al. Among authors: giovannetti e. Curr Pharm Des. 2018;24(39):4601-4604. doi: 10.2174/1381612825666190119125804. Curr Pharm Des. 2018. PMID: 30659532 Review.

10

Role of c-MET Inhibitors in Overcoming Drug Resistance in Spheroid Models of Primary Human Pancreatic Cancer and Stellate Cells.

Firuzi O, Che PP, El Hassouni B, Buijs M, Coppola S, Löhr M, Funel N, Heuchel R, Carnevale I, Schmidt T, Mantini G, Avan A, Saso L, Peters GJ, Giovannetti E. Firuzi O, et al. Among authors: giovannetti e. Cancers (Basel). 2019 May 8;11(5):638. doi: 10.3390/cancers11050638. Cancers (Basel). 2019. PMID: 31072019 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

400 results

Search Page